Compare GLMD & TOPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GLMD | TOPS |
|---|---|---|
| Founded | 2000 | 2000 |
| Country | Israel | Greece |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2M | 4.9M |
| IPO Year | 2013 | 2004 |
| Metric | GLMD | TOPS |
|---|---|---|
| Price | $4.37 | $0.79 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 115.9K | ★ 179.1K |
| Earning Date | 05-21-2026 | 04-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $2.14 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.41 | $0.62 |
| 52 Week High | $5.45 | $7.40 |
| Indicator | GLMD | TOPS |
|---|---|---|
| Relative Strength Index (RSI) | 86.02 | 49.56 |
| Support Level | $0.56 | $0.70 |
| Resistance Level | N/A | $0.87 |
| Average True Range (ATR) | 0.19 | 0.06 |
| MACD | 0.45 | 0.01 |
| Stochastic Oscillator | 75.89 | 39.80 |
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. The company focuses on the development of Aramchol for combination therapy for GI oncological indications. The company is actively pursuing opportunities in the biotech and medtech spaces to expand and diversify its product pipeline targeting GI, cardiometabolic indications and other product candidates.
TOP Ships Inc owns tanker vessels throughout the world. The Company is an international owner and operator of modern, fuel-efficient eco-tanker vessels, focusing on the transportation of crude oil, petroleum products (both clean and dirty), and bulk liquid chemicals. It generates revenue from the Time Charter agreements. The company operates in two reportable segments: (i) the tanker segment and (ii) the megayacht segment.